News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Courtagen Life Sciences, Inc. To Provide Genetic Profiling Of Children With Intractable Epilepsy To Support Clinical Developments With Cannabidiol



4/2/2014 8:44:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, an innovative molecular information company, announces a new comprehensive epilepsy sequencing test designed to sequence 489 genes known to be involved in epilepsy, antiepileptic drug metabolism, and endocannabinoid regulation. This panel is to be the first deployed in the genetic analysis of over 100 children suffering from intractable epilepsy syndromes.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES